Posterior reversible encephalopathy syndrome (PRES) associated with ovarian cancer and voltage-gated potassium channel antibodies: A case report

Breast CancerGastrointestinal Cancer

A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma

Hered Cancer Clin Pract.

Kientz C, Joly MO, Faivre L, Clemenson A, Dalac S, Lepage C, Chapusot C, Jacquot C, Schiappa R, Lebrun M

doi: 10.1186/s13053-017-0066-9.

COMMENTED

Gynecologic Cancer

Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss

Cancer Biol Ther.

Frisone D, Charrier M, Clement S, Christinat Y, Thouvenin L, Homicsko K, Michielin O, Bodmer A, Chappuis PO, McKee TA, Tsantoulis P

doi: 10.1080/15384047.2019.1685291.

Gynecologic Cancer

The diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study

BJOG.

Mahyuddin AP, Liu L, Zhao C, Narasimhan K, Salto-Tellez M, Pang BNK, Lim DGS, Annalamai L, Chan JKY, Lim TYK, Biswas A, Rice G, Razvi K, Choolani M

doi: 10.1111/

Gynecologic Cancer

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer

Eur J Cancer.

Michielsen K, Dresen R, Vanslembrouck R, De Keyzer F, Amant F, Mussen E, Leunen K, Berteloot P, Moerman P, Vergote I, Vandecaveye V

doi: 10.1016/j.ejca.2017.06.010.

Breast CancerGastrointestinal CancerGynecologic Cancer

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report

World J Surg Oncol.

Mori R, Futamura M, Morimitsu K, Saigo C, Miyazaki T, Yoshida K

doi: 10.1186/s12957-017-1185-5.

Gynecologic Cancer

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient

Cell.

Jiménez-Sánchez A, Memon D, Pourpe S, Veeraraghavan H, Li Y, Vargas HA, Gill MB, Park KJ, Zivanovic O, Konner J, Ricca J, Zamarin D, Walther T, Aghajanian C, Wolchok JD, Sala E, Merghoub T, Snyder A, Miller ML

doi: 10.1016/j.cell.2017.07.025.

Gynecologic Cancer

Exceptional Response to Olaparib in a Patient With Recurrent Ovarian Cancer and an Entire BRCA1 Germline Gene Deletion

J Natl Compr Canc Netw.

Randall M, Burgess K, Buckingham L, Usha L

doi: 10.6004/jnccn.2019.7378.

Gynecologic Cancer

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses

Gynecol Oncol.

Bogani G, Tagliabue E, Ditto A, Signorelli M, Martinelli F, Casarin J, Chiappa V, Dondi G, Leone Roberti Maggiore U, Scaffa C, Borghi C, Montanelli L, Lorusso D, Raspagliesi F

doi: 10.1016/j.ygyno.2017.07.139.

Gynecologic Cancer

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Lancet Oncol.

Pujade-Lauraine E, Ledermann JA, Selle F, Gebski V, Penson RT, Oza AM, Korach J, Huzarski T, Poveda A, Pignata S, Friedlander M, Colombo N, Harter P, Fujiwara K, Ray-Coquard I, Banerjee S, Liu J, Lowe ES, Bloomfield R, Pautier P; SOLO2/ENGOT-Ov21 investigators

doi: 10.1016/

Related content

A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma

Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss

The diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient

Exceptional Response to Olaparib in a Patient With Recurrent Ovarian Cancer and an Entire BRCA1 Germline Gene Deletion

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial